Neurological Services of Orlando

Orlando, Florida 32806

0 studies enrolling now · 12 studies all time

What they study most

Autoimmune Diseases of the Nervous System, Brain Atrophy, Disease Progression, Generalized Myasthenia Gravis, Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Relapsing-Remitting, Myasthenia Gravis, Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder, Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis

Studies at this site

• A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis — Running, not enrolling
• A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis — Running, not enrolling
• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
• A Study of RVT-1401 in Myasthenia Gravis (MG) Patients — Completed
• An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients — Completed
• Observational Registry of Acthar Gel for Participants With Multiple Sclerosis Relapse — Completed
• A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study) — Stopped early
• Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis — NO_LONGER_AVAILABLE
• Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis — Completed
• A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis — Completed